MedPath

Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion

Phase 1
Completed
Conditions
Healthy
Interventions
Registration Number
NCT02243813
Lead Sponsor
Johns Hopkins University
Brief Summary

The current protocol is a pilot study of the effects and possible utility of psilocybin-facilitated experiences for professional religious leaders.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria
  • Current or past history of meeting Diagnostic and Statistics Manual (DSM)-5 criteria for Schizophrenia, Psychotic Disorder (unless substance-induced or due to a medical condition), or Bipolar I or II Disorder
  • Current or past history within the last 5 years of meeting DSM-5 criteria for alcohol or substance use disorder (excluding caffeine and nicotine) or severe major depression
  • Have a first or second-degree relative with Schizophrenia, Psychotic Disorder (unless substance induced or due to a medical condition), or Bipolar I or II Disorder
  • Has a psychiatric condition judged to be incompatible with establishment of rapport or safe exposure to psilocybin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Immediate ParticipationPsilocybinParticipants will begin psilocybin intervention immediately after study enrollment.
Delayed ParticipationPsilocybinParticipants will begin the psilocybin intervention 6 months after study enrollment.
Primary Outcome Measures
NameTimeMethod
Interim Questionnaire6 months after enrollment

This questionnaire asks about experiences and changes in attitudes, mood and behavior that occurred during the past 5 months. The questionnaire includes questions about salient spiritual experiences, changes in spiritual practices, changes in attitudes, moods, social interactions, and other behaviors related to participants' religious/spiritual vocation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Behavioral Biology Research Center, Johns Hopkins Bayview

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath